Filings

ASX Filings

Date	Description
October 26, 2018	Opthea Reports Positive Data from Ph1b DME Study of OPT-302
October 26, 2018	Notice of Annual General Meeting and Proxy Form
October 26, 2018	Opthea CEO Presentation of Trial Updates at OIS@AAO 2018
October 24, 2018	Opthea To Present at the Ophthalmology Innovation Summit
October 22, 2018	Appendix 3B

There are no SEC filings available.

Data provided by Kaleidoscope.